
itopride
Sign in to saveAlso known as N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide
Itopride (INN; brand name Ganaton) is a prokinetic benzamide derivative. These drugs inhibit dopamine and acetylcholine esterase enzyme and have a gastrokinetic effect. Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions. It is a combined D2 receptor antagonist and acetylcholinesterase inhibitor. Itopride is the dimethoxy analog of trimethobenzamide.
Key facts
- Drug.KEGG
- D08094
- Drug.KEGG2
- D02729
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 444538072
- Drug.image
- Itopride.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 260
- Drug.image2
- 3D Itopride.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Ganaton
- Drug.legal_status
- Rx-only
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- A03
- Drug.ATC_suffix
- FA07
- Drug.bioavailability
- ~60% (Tmax = 35±5 min)
- Drug.protein_bound
- 96%
- Drug.metabolism
- Extensive hepatic (FMO1 and FMO3), primarily N-oxidation
- Drug.elimination_half life
- 5.7±0.3 hours
via Wikipedia infobox
Wikidata facts
- Mass
- 358.189257
Show 3 more facts
- chemical formula
- C₂₀H₂₆N₂O₄
- canonical SMILES
- CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC
- Commons category
- Itopride
Sources (2)
via Wikidata · CC0
~6 min read
Article
10 sectionsContents
- Medical uses
- Adverse drug reactions
- Cardiac studies
- Pharmacology
- Pharmacokinetics
- Mechanism of action
- Society and culture
- Names
- References
- External links
Itopride (INN; brand name Ganaton) is a prokinetic benzamide derivative. These drugs inhibit dopamine and acetylcholine esterase enzyme and have a gastrokinetic effect. Itopride is indicated for the treatment of functional dyspepsia and other gastrointestinal conditions. It is a combined D2 receptor antagonist and acetylcholinesterase inhibitor. Itopride is the dimethoxy analog of trimethobenzamide.
==Medical uses== thumb|240px|A blister package of Ganaton (Itopride) 50 mg tablets intended for distribution in the Slovak Republic. Typically, itopride is indicated in the treatment of GI symptoms caused by reduced GI motility: dyspepsia of a non-ulcer/dysmotility type (gastric "fullness", discomfort, and possible pain) gastroparesis (delayed gastric emptying) anorexia heartburn regurgitation bloating nausea and vomiting other possible gastric, prolactin, or dopamine related conditions
Gallery (2)
Available in 9 languages
via Wikidata sitelinks · CC0